Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Clinical trial NCT01261728 · COMPLETED
Trial details
- NCT number
- NCT01261728
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-14
- Primary completion
- 2025-08-06
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.